Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2094115 Target Snapshot

MAP kinase p38 · PROTEIN FAMILY · Homo sapiens

1,050Compounds
421Assays
3Approved Drugs
1,155.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O15264. Use UniProt O15264 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O15264 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats MAP kinase p38 as ChEMBL target CHEMBL2094115, mapped to UniProt O15264. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
MAP kinase p38
PROTEIN FAMILY · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2094115
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O15264
Mitogen-activated protein kinase 13
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether MAP kinase p38 is the right protein anchor across sources, using UniProt O15264 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMitogen-activated protein kinase 13
UniProt AccessionO15264
Component TypeProtein
Sequence Length365 aa

Mitogen-activated protein kinase 13

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as MAP kinase p38, mapped to UniProt O15264. ChEMBL maps the protein component as Mitogen-activated protein kinase 13. Sequence length is 365 aa.

Mapped IDO15264
Review nameMAP kinase p38
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Approved
6
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC501,021.0
KI20.0
EC5028.0
KD86.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL194813 10.33 Ki 0.047 Preclinical
CHEMBL363643 10.3 Ki 0.05 Preclinical
CHEMBL196741 10.24 Ki 0.057 Preclinical
CHEMBL197206 10.24 Ki 0.057 Preclinical
CHEMBL103667 10.01 Kd 0.097 Clinical
CHEMBL318810 10.0 Kd 0.1 Preclinical
CHEMBL305178 9.96 IC50 0.11 Preclinical
CHEMBL195532 9.82 Ki 0.15 Preclinical
CHEMBL545353 9.82 IC50 0.15 Preclinical
CHEMBL197351 9.8 Ki 0.16 Preclinical
Distribution

pChEMBL Value Distribution

61
5.0
98
5.5
163
6.0
148
6.5
129
7.0
96
7.5
70
8.0
44
8.5
34
9.0
9
9.5
pChEMBL
Approved Drugs

Approved Drugs

NALFURAFINE
CHEMBL267495
Approved 2009
DASATINIB
CHEMBL5416410
Approved 2006
Assay Landscape

Assay Landscape

421
Total Assays
444
Tested Compounds
3
Assay Types
Binding — 367 assays, 444 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 198 27 7.0
protein format 125 319 6.9
assay format 38 94 6.9
tissue-based format 4 4 8.5
mitochondrion format 2 0
Functional — 53 assays, 319 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 23 152 7.0
cell-based format 17 115 6.4
tissue-based format 13 52 6.2
ADME — 1 assays, 6 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 1 6 6.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine